242 related articles for article (PubMed ID: 14640041)
1. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan.
Ikeda S; Takei Y; Tokuda T; Nakazato M; Ando Y
Amyloid; 2003 Aug; 10 Suppl 1():39-47. PubMed ID: 14640041
[TBL] [Abstract][Full Text] [Related]
2. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S
Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088
[TBL] [Abstract][Full Text] [Related]
3. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan.
Sobue G; Koike H; Misu K; Hattori N; Yamamoto M; Ikeda S; Ando Y; Nakazato M; Inukai A
Amyloid; 2003 Aug; 10 Suppl 1():32-8. PubMed ID: 14640040
[TBL] [Abstract][Full Text] [Related]
5. [Application to transthyretin analysis].
Ueda M; Ando Y
Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
[TBL] [Abstract][Full Text] [Related]
8. A Swedish family with the rare Phe33Leu transthyretin mutation.
Holmgren G; Hellman U; Jonasson J; Lundgren HE; Westermark P; Suhr OB
Amyloid; 2005 Sep; 12(3):189-92. PubMed ID: 16194875
[TBL] [Abstract][Full Text] [Related]
9. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
Ikeda S; Nakazato M; Ando Y; Sobue G
Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
[TBL] [Abstract][Full Text] [Related]
10. The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Morozumi S; Kawagashira Y; Iijima M; Yamamoto M; Hattori N; Tanaka F; Nakamura T; Hirayama M; Ando Y; Ikeda S; Sobue G
Amyloid; 2009; 16(3):142-8. PubMed ID: 19626479
[TBL] [Abstract][Full Text] [Related]
11. Late-onset familial amyloid polyneuropathy in Japan.
Koike H; Sobue G
Amyloid; 2012 Jun; 19 Suppl 1():55-7. PubMed ID: 22506939
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
[TBL] [Abstract][Full Text] [Related]
13. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
Ando Y
Rinsho Byori; 2000 May; 48(5):425-9. PubMed ID: 10892290
[TBL] [Abstract][Full Text] [Related]
14. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.
Nakamura M; Yamashita T; Ueda M; Obayashi K; Sato T; Ikeda T; Washimi Y; Hirai T; Kuwahara Y; Yamamoto MT; Uchino M; Ando Y
Neurology; 2005 Oct; 65(7):1051-6. PubMed ID: 16217058
[TBL] [Abstract][Full Text] [Related]
15. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients.
Oguchi K; Takei Y; Ikeda S
Amyloid; 2006 Jun; 13(2):99-107. PubMed ID: 16911964
[TBL] [Abstract][Full Text] [Related]
16. Clinical picture and outcome of transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients.
Ikeda S
Clin Chem Lab Med; 2002 Dec; 40(12):1257-61. PubMed ID: 12553427
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report.
Oide T; Arima K; Yamazaki M; Hanyu N; Ikeda S
Amyloid; 2004 Sep; 11(3):191-9. PubMed ID: 15523922
[TBL] [Abstract][Full Text] [Related]
18. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
[TBL] [Abstract][Full Text] [Related]
19. Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study.
Mazzeo A; Toscano A; Stromillo ML; Battaglini M; Messina C; Federico A; Vita G; De Stefano N
J Neurol Sci; 2006 Jul; 246(1-2):31-5. PubMed ID: 16530227
[TBL] [Abstract][Full Text] [Related]
20. Clinical variant of familial amyloid polyneuropathy.
Quan D; Cohen JA
Muscle Nerve; 2002 Sep; 26(3):417-20. PubMed ID: 12210373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
